These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 31253194)
1. Multi-window CT based Radiomic signatures in differentiating indolent versus aggressive lung cancers in the National Lung Screening Trial: a retrospective study. Lu H; Mu W; Balagurunathan Y; Qi J; Abdalah MA; Garcia AL; Ye Z; Gillies RJ; Schabath MB Cancer Imaging; 2019 Jun; 19(1):45. PubMed ID: 31253194 [TBL] [Abstract][Full Text] [Related]
2. Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT? Digumarthy SR; Padole AM; Rastogi S; Price M; Mooradian MJ; Sequist LV; Kalra MK Cancer Imaging; 2019 Jun; 19(1):36. PubMed ID: 31182167 [TBL] [Abstract][Full Text] [Related]
3. A comparative study to evaluate CT-based semantic and radiomic features in preoperative diagnosis of invasive pulmonary adenocarcinomas manifesting as subsolid nodules. Wu YJ; Liu YC; Liao CY; Tang EK; Wu FZ Sci Rep; 2021 Jan; 11(1):66. PubMed ID: 33462251 [TBL] [Abstract][Full Text] [Related]
4. A combination of radiomic features, clinic characteristics, and serum tumor biomarkers to predict the possibility of the micropapillary/solid component of lung adenocarcinoma. Xing X; Li L; Sun M; Zhu X; Feng Y Ther Adv Respir Dis; 2024; 18():17534666241249168. PubMed ID: 38757628 [TBL] [Abstract][Full Text] [Related]
5. The predictive value of CT-based radiomics in differentiating indolent from invasive lung adenocarcinoma in patients with pulmonary nodules. She Y; Zhang L; Zhu H; Dai C; Xie D; Xie H; Zhang W; Zhao L; Zou L; Fei K; Sun X; Chen C Eur Radiol; 2018 Dec; 28(12):5121-5128. PubMed ID: 29869172 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of Invasive Lung Adenocarcinoma Based on Chest CT Radiomic Features of Part-Solid Pulmonary Nodules: A Multicenter Study. Wu G; Woodruff HC; Shen J; Refaee T; Sanduleanu S; Ibrahim A; Leijenaar RTH; Wang R; Xiong J; Bian J; Wu J; Lambin P Radiology; 2020 Nov; 297(2):451-458. PubMed ID: 32840472 [TBL] [Abstract][Full Text] [Related]
7. Utility of CT radiomics for prediction of PD-L1 expression in advanced lung adenocarcinomas. Yoon J; Suh YJ; Han K; Cho H; Lee HJ; Hur J; Choi BW Thorac Cancer; 2020 Apr; 11(4):993-1004. PubMed ID: 32043309 [TBL] [Abstract][Full Text] [Related]
8. Comparison of a radiomic biomarker with volumetric analysis for decoding tumour phenotypes of lung adenocarcinoma with different disease-specific survival. Yuan M; Zhang YD; Pu XH; Zhong Y; Li H; Wu JF; Yu TF Eur Radiol; 2017 Nov; 27(11):4857-4865. PubMed ID: 28523350 [TBL] [Abstract][Full Text] [Related]
9. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma. Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901 [TBL] [Abstract][Full Text] [Related]
10. Performance of radiomics models derived from different CT reconstruction parameters for lung cancer risk prediction. Zhang R; Shi J; Liu S; Chen B; Li W BMC Pulm Med; 2023 Apr; 23(1):132. PubMed ID: 37081469 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of UTE-MRI-based radiomics model for prediction of histopathologic subtype of lung adenocarcinoma: in comparison with CT-based radiomics model. Lee S; Lee CY; Kim NY; Suh YJ; Lee HJ; Yong HS; Kim HR; Kim YJ Eur Radiol; 2024 May; 34(5):3422-3430. PubMed ID: 37840100 [TBL] [Abstract][Full Text] [Related]
12. Solid Components in the Mediastinal Window of Computed Tomography Define a Distinct Subtype of Subsolid Nodules in Clinical Stage I Lung Cancers. Yin J; Xi J; Liang J; Zhan C; Jiang W; Lin Z; Xu S; Wang Q Clin Lung Cancer; 2021 Jul; 22(4):324-331. PubMed ID: 33789831 [TBL] [Abstract][Full Text] [Related]
13. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT? Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209 [TBL] [Abstract][Full Text] [Related]
14. Volume doubling time and radiomic features predict tumor behavior of screen-detected lung cancers. Pérez-Morales J; Lu H; Mu W; Tunali I; Kutuk T; Eschrich SA; Balagurunathan Y; Gillies RJ; Schabath MB Cancer Biomark; 2022; 33(4):489-501. PubMed ID: 35491768 [TBL] [Abstract][Full Text] [Related]
15. Prediction of Interval Growth of Lung Adenocarcinomas Manifesting as Persistent Subsolid Nodules ≤3 cm Based on Radiomic Features. Wu FZ; Wu YJ; Chen CS; Tang EK Acad Radiol; 2023 Dec; 30(12):2856-2869. PubMed ID: 37080884 [TBL] [Abstract][Full Text] [Related]
16. Distinguishing granulomas from adenocarcinomas by integrating stable and discriminating radiomic features on non-contrast computed tomography scans. Khorrami M; Bera K; Thawani R; Rajiah P; Gupta A; Fu P; Linden P; Pennell N; Jacono F; Gilkeson RC; Velcheti V; Madabhushi A Eur J Cancer; 2021 May; 148():146-158. PubMed ID: 33743483 [TBL] [Abstract][Full Text] [Related]
17. Integrative nomogram of intratumoral, peritumoral, and lymph node radiomic features for prediction of lymph node metastasis in cT1N0M0 lung adenocarcinomas. Das SK; Fang KW; Xu L; Li B; Zhang X; Yang HF Sci Rep; 2021 May; 11(1):10829. PubMed ID: 34031529 [TBL] [Abstract][Full Text] [Related]
18. Dependence of radiomic features on pixel size affects the diagnostic performance of radiomic signature for the invasiveness of pulmonary ground-glass nodule. Tao G; Yin L; Shi D; Ye J; Lu Z; Zhou Z; Yu Y; Ye X; Yu H Br J Radiol; 2021 Feb; 94(1118):20200089. PubMed ID: 33353396 [TBL] [Abstract][Full Text] [Related]
19. Radiomics for lung adenocarcinoma manifesting as pure ground-glass nodules: invasive prediction. Sun Y; Li C; Jin L; Gao P; Zhao W; Ma W; Tan M; Wu W; Duan S; Shan Y; Li M Eur Radiol; 2020 Jul; 30(7):3650-3659. PubMed ID: 32162003 [TBL] [Abstract][Full Text] [Related]
20. CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses. Mei D; Luo Y; Wang Y; Gong J Cancer Imaging; 2018 Dec; 18(1):52. PubMed ID: 30547844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]